Cargando…
A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma
In order to find a suppressor(s) of tumor progression in vivo for head and neck squamous cell carcinoma (HNSCC), we searched for molecules downregulated in HNSCC cells when the cells were treated with epidermal growth factor (EGF), whose receptor is frequently overactivated in HNSCC. The expression...
Autor principal: | Hata, Ryu-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671715/ https://www.ncbi.nlm.nih.gov/pubmed/23762619 http://dx.doi.org/10.5402/2012/797619 |
Ejemplares similares
-
Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice
por: Hata, Ryu-Ichiro, et al.
Publicado: (2015) -
Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma
por: Kondo, T, et al.
Publicado: (2016) -
Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma
por: Guan, Jian, et al.
Publicado: (2021) -
Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney–Expressed Chemokine (Brak) in Macrophage Development
por: Kurth, Isabel, et al.
Publicado: (2001) -
CXCL14: the Swiss army knife chemokine
por: Benarafa, Charaf, et al.
Publicado: (2015)